AMLODIPINE BESYLATE
- Product NDC
- 70518-0297
- 11-digit product format
- 705180297
- Labeler code
- 70518
- Product ID
- 70518-0297_50128613-4e6a-bb72-e063-6394a90a0042
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- AMLODIPINE BESYLATE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA077073
- Marketing category
- ANDA
- Marketing start
- 2017-03-08
- Substance
- AMLODIPINE BESYLATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- AMLODIPINE BESYLATE
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| AMLODIPINE BESYLATE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 864V2Q084H |
| Rxcui | 308135 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 70518-0297-0 | 2023-12-12 | C162847 | 48780-1 | d6a99b39-bda8-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 70518-0297-0 | 2023-12-12 | C162847 | 48780-1 | d6a99b39-bda8-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 70518-0297-0 | 2023-12-12 | C162847 | 48780-1 | d6a99b39-bda8-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 70518-0297-1 | 2023-12-12 | C162847 | 48780-1 | d6a99b39-bda8-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 70518-0297-1 | 2023-12-12 | C162847 | 48780-1 | d6a99b39-bda8-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 70518-0297-1 | 2023-12-12 | C162847 | 48780-1 | d6a99b39-bda8-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 70518-0297-2 | 2023-12-12 | C162847 | 48780-1 | d6a99b39-bda8-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 70518-0297-2 | 2023-12-12 | C162847 | 48780-1 | d6a99b39-bda8-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 70518-0297-2 | 2023-12-12 | C162847 | 48780-1 | d6a99b39-bda8-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 70518-0297-0 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-bda8-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 70518-0297-0 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-bda8-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 70518-0297-0 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-bda8-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 70518-0297-1 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-bda8-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 70518-0297-1 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-bda8-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 70518-0297-1 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-bda8-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 70518-0297-2 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-bda8-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 70518-0297-2 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-bda8-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
| 70518-0297-2 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-bda8-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral administration Initial U.S. Approval: 1992 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70518-0297-0 | AMLODIPINE BESYLATE | 30 in 1 BLISTER PACK | TABLET | 30 | | 14 |
| 70518-0297-1 | AMLODIPINE BESYLATE | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | | 14 |
| 70518-0297-2 | AMLODIPINE BESYLATE | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 14 |
| 70518-0297-3 | AMLODIPINE BESYLATE | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | | 14 |
| 70518-0297-4 | AMLODIPINE BESYLATE | 50 in 1 BOX | TABLET | 50 | | 14 |
| 70518-0297-5 | AMLODIPINE BESYLATE | 1 in 1 POUCH | TABLET | 1 | | 14 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70518-0297 | AMLODIPINE BESYLATE TABLET [REMEDYREPACK INC.] | 10 | Current NDC, Legacy NDC, 6 package rows | 20250504_a6fa364c-3ad6-4bf9-b9ee-5ec3b1a7eb55.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-0297-0 | 70518029700 | 30 TABLET in 1 BLISTER PACK (70518-0297-0) | 30 tablet | 2017-03-08 | 0000-00-00 | No | No | Current |
| 70518-0297-1 | 70518029701 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-0297-1) | 90 tablet | 2017-04-24 | 0000-00-00 | No | No | Current |
| 70518-0297-2 | 70518029702 | 30 in 1 BOTTLE, PLASTIC | | | | | | Historical |
| 70518-0297-3 | 70518029703 | 90 in 1 BOTTLE, PLASTIC | | | | | | Historical |
| 70518-0297-4 | 70518029704 | 50 POUCH in 1 BOX (70518-0297-4) / 1 TABLET in 1 POUCH (70518-0297-5) | 50 pouch | 2026-04-22 | | No | No | Historical |
| 70518-0297-5 | 70518029705 | 1 in 1 POUCH | | | | | | Historical |